-+ 0.00%
-+ 0.00%
-+ 0.00%

Theriva Biologics Q2 EPS $(0.07) Misses $(0.05) Estimate

Benzinga·08/11/2026 12:06:34
Listen to the news
Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 96.37 percent increase over losses of $(1.93) per share from the same period last year.